The aims of the present study were to (1) assess relationships between running performance and parasympathetic function both at rest and following exercise, and (2) examine changes in heart rate (HR)-derived indices throughout an 8-week period training program in runners. In 14 moderately trained runners (36 +/- 7 years), resting vagal-related HR variability (HRV) indices were measured daily, while exercise HR and post-exercise HR recovery (HRR) and HRV indices were measured fortnightly. Maximal aerobic speed (MAS) and 10 km running performance were assessed before and after the training intervention. Correlations (r > 0.60, P < 0.01) were observed between changes in vagal-related indices and changes in MAS and 10 km running time. Exercise HR decreased progressively during the training period (P < 0.01). In the 11 subjects who lowered their 10 km running time >0.5% (responders), resting vagal-related indices showed a progressively increasing trend (time effect P = 0.03) and qualitative indications of possibly and likely higher values during week 7 [+7% (90% CI -3.7;17.0)] and week 9 [+10% (90% CI -1.5;23)] compared with pre-training values, respectively. Post-exercise HRV showed similar changes, despite less pronounced between-group differences. HRR showed a relatively early possible decrease at week 3 [-20% (90% CI -42;10)], with only slight reductions near the end of the program. The results illustrate the potential of resting, exercise and post-exercise HR measurements for both assessing and predicting the impact of aerobic training on endurance running performance.
In this study, we compared the reliability of short-term resting heart rate (HR) variability (HRV) and postexercise parasympathetic reactivation (i.e., HR recovery (HRR) and HRV) indices following either submaximal or supramaximal exercise. On 4 different occasions, beat-to-beat HR was recorded in 15 healthy males (21.5 ± 1.4 yr) during 5 min of seated rest, followed by submaximal (Sub) and supramaximal (Supra) exercise bouts; both exercise bouts were followed by 5 min of seated recovery. Reliability of all HR-derived indices was assessed by the typical error of measurement expressed as a coefficient of variation (CV,%). CV for HRV indices ranged from 4 to 17%, 7 to 27% and 41 to 82% for time domain, spectral and ratio indices, respectively. The CV for HRR ranged from 15 to 32%. Spectral CVs for HRV were lower at rest compared with Supra (e.g., natural logarithm of the high frequency range (LnHF); 12.6 vs. 26.2%; P=0.02). HRR reliability was not different between Sub and Supra (25 vs. 14%; P=0.10). The present study found discrepancy in the CVs of vagal-related heart rate indices; a finding that should be appreciated when assessing changes in these variables. Further, Supra exercise was shown to worsen the reliability of HRV-spectral indices.
The aims of the current study were to examine the magnitude of between-GPS-models differences in commonly reported running-based measures in football, examine between-units variability, and assess the effect of software updates on these measures. Fifty identical-brand GPS units (15 SPI-proX and 35 SPIproX2, 15 Hz, GPSports, Canberra, Australia) were attached to a custom-made plastic sled towed by a player performing simulated match running activities. GPS data collected during training sessions over 4 wk from 4 professional football players (N = 53 files) were also analyzed before and after 2 manufacturer-supplied software updates. There were substantial differences between the different models (eg, standardized difference for the number of acceleration >4 m/s2 = 2.1; 90% confidence limits [1.4, 2.7], with 100% chance of a true difference). Between-units variations ranged from 1% (maximal speed) to 56% (number of deceleration >4 m/s2). Some GPS units measured 2-6 times more acceleration/deceleration occurrences than others. Software updates did not substantially affect the distance covered at different speeds or peak speed reached, but 1 of the updates led to large and small decreases in the occurrence of accelerations (-1.24; -1.32, -1.15) and decelerations (-0.45; -0.48, -0.41), respectively. Practitioners are advised to apply care when comparing data collected with different models or units or when updating their software. The metrics of accelerations and decelerations show the most variability in GPS monitoring and must be interpreted cautiously.
The aim of the present study was to verify the validity of using exercise heart rate (HRex), HR recovery (HRR) and post-exercise HR variability (HRV) during and after a submaximal running test to predict changes in physical performance over an entire competitive season in highly trained young soccer players. Sixty-five complete data sets were analyzed comparing two consecutive testing sessions (3-4 months apart) collected on 46 players (age 15.1 ± 1.5 years). Physical performance tests included a 5-min run at 9 km h(-1) followed by a seated 5-min recovery period to measure HRex, HRR and HRV, a counter movement jump, acceleration and maximal sprinting speed obtained during a 40-m sprint with 10-m splits, repeated-sprint performance and an incremental running test to estimate maximal cardiorespiratory function (end test velocity V (Vam-Eval)). Possible changes in physical performance were examined for the players presenting a substantial change in HR measures over two consecutive testing sessions (greater than 3, 13 and 10% for HRex, HRR and HRV, respectively). A decrease in HRex or increase in HRV was associated with likely improvements in V (Vam-Eval); opposite changes led to unclear changes in V (Vam-Eval). Moderate relationships were also found between individual changes in HRR and sprint [r = 0.39, 90% CL (0.07;0.64)] and repeated-sprint performance [r = -0.38 (-0.05;-0.64)]. To conclude, while monitoring HRex and HRV was effective in tracking improvements in V (Vam-Eval), changes in HRR were moderately associated with changes in (repeated-)sprint performance. The present data also question the use of HRex and HRV as systematic markers of physical performance decrements in youth soccer players.
The aim of the present study was to examine, in highly trained young soccer players, the mechanical horizontal determinants of acceleration (Acc) and maximal sprinting speed (MSS). Eighty-six players (14.1 ± 2.4 year) performed a 40-m sprint to assess Acc and MSS. Speed was measured with a 100-Hz radar, and theoretical maximal velocity (V), horizontal force (F) and horizontal power (P) were calculated. Within each age group, players were classified as high Acc/fast MSS (>2% faster than group mean), medium (between -2% and +2%), and low/slow (>2% slower). Acc and MSS were very largely correlated (-0.79; 90% confidence limit [-0.85; -0.71]). The determinants (multiple regression r = 0.84 [0.78; 0.89]) of Acc were V (partial r: 0.80 [0.72; 0.86]) and F (0.57 [0.44; 0.68]); those of MSS (r = 0.96 [0.94; 0.97]) were V (0.96 [0.94; 0.97]) and P (0.73 [0.63; -0.80]). High/Med have likely greater F (Cohen's d: +0.8 [0.0; 1.5]), V (+0.6 [-0.1; 1.3]) and P (+0.9 [0.2; 1.7]) than Low/Med. High/Fast have an almost certainly faster V (+2.1 [1.5; 2.7]) and a likely greater P (+0.6 [-0.1; 1.3]) than High/Med, with no clear differences in F (-0.0 [-0.7; 0.6]). Speed may be a generic quality, but the mechanical horizontal determinants of Acc and MSS differ. While maximal speed training may improve both Acc and MSS, improving horizontal force production capability may be efficient to enhance sprinting performance over short distances.
The 30-15 Intermittent Fitness Test (30-15IFT) is an attractive alternative to classic continuous incremental field tests for defining a reference velocity for interval training prescription in team sport athletes. The aim of the present study was to compare cardiorespiratory and autonomic responses to 30-15IFT with those observed during a standard continuous test (CT). In 20 team sport players (20.9 +/- 2.2 years), cardiopulmonary parameters were measured during exercise and for 10 minutes after both tests. Final running velocity, peak lactate ([La]peak), and rating of perceived exertion (RPE) were also measured. Parasympathetic function was assessed during the postexercise recovery phase via heart rate (HR) recovery time constant (HRR[tau]) and HR variability (HRV) vagal-related indices. At exhaustion, no difference was observed in peak oxygen uptake VO2peak), respiratory exchange ratio, HR, or RPE between 30-15IFT and CT. In contrast, 30-15IFT led to significantly higher minute ventilation, [La]peak, and final velocity than CT (p < 0.05 for all parameters). All maximal cardiorespiratory variables observed during both tests were moderately to well correlated (e.g., r = 0.76, p = 0.001 for [latin capital VO2peak). Regarding ventilatory thresholds (VThs), all cardiorespiratory measurements were similar and well correlated between the 2 tests. Parasympathetic function was lower after 30-15IFT than after CT, as indicated by significantly longer HHR[tau] (81.9 +/- 18.2 vs. 60.5 +/- 19.5 for 30-15IFT and CT, respectively, p < 0.001) and lower HRV vagal-related indices (i.e., the root mean square of successive R-R intervals differences [rMSSD]: 4.1 +/- 2.4 and 7.0 +/- 4.9 milliseconds, p < 0.05). In conclusion, the 30-15IFT is accurate for assessing VThs and VO2peak, but it alters postexercise parasympathetic function more than a continuous incremental protocol.
This study assessed the relationship between peak match speed (PMS) and maximal sprinting speed (MSS) in regard to age and playing positions. MSS and absolute PMS (PMSAbs) were collected from 180 male youth soccer players (U13-U17, 15.0 ± 1.2 y, 161.5 ± 9.2 cm, and 48.3 ± 8.7 kg). The fastest 10-m split over a 40-m sprint was used to determine MSS. PMSAbs was recorded using a global positioning system and was also expressed as a percentage of MSS (PMSRel). Sprint data were compared between age groups and between playing positions. Results showed that regardless of age and playing positions, faster players were likely to reach higher PMSAbs and possibly lower PMSRel. Despite a lower PMSAbs than in older groups (eg, 23.4 ± 1.8 vs 26.8 ± 1.9 km/h for U13 and U17, respectively, ES = 1.9 90%, confidence limits [1.6;2.1]), younger players reached a greater PMSRel (92.0% ± 6.3% vs. 87.2% ± 5.7% for U13 and U17, respectively, ES = -0.8 90% CL [-1.0;-0.5]). Playing position also affected PMSAbs and PMSRel, as strikers were likely to reach higher PMSAbs (eg, 27.0 ± 2.7 vs 23.6 ± 2.2 km/h for strikers and central midfielders, respectively, ES = 2.0 [1.7;2.2]) and PMSRel (eg, 93.6% ± 5.2% vs 85.3% ± 6.5% for strikers and central midfielders, respectively, ES = 1.0 [0.7;1.3]) than all other positions. The findings confirm that age and playing position affect the absolute and relative intensity of speed-related actions during matches.
The purpose of this study was to investigate the effect of exercise-induced plasma volume expansion on post-exercise parasympathetic reactivation. Before (D(0)) and 2 days after (D(+2)) a supramaximal exercise session, 11 men (21.4 +/- 2.6 years and BMI = 23.0 +/- 1.4) performed 6-min of submaximal running where heart rate (HR) recovery (HRR) and HR variability (HRV) indices were calculated during the first 10 min of recovery. Relative plasma volume changes (PV) were calculated using changes in hematocrit and hemoglobin measured over consecutive mornings from D(0) to D(+2). Parasympathetic reactivation was evaluated through HRR and vagal-related indexes calculated during a stationary period of recovery. Compared with D(0), PV (+4.8%, P < 0.01) and all vagal-related HRV indices were significantly higher at D(+2) (all P < 0.05). HRR was not different between trials. Changes in HRV indices, but not HRR, were related to PV (all P < 0.01). HRR and HRV indices characterize distinct independent aspects of cardiac parasympathetic function, with HRV indices being more sensitive to changes in plasma volume than HRR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.